Sight Sciences, Inc.
SGHT
$5.49
-$0.01-0.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.51% | 6.87% | -1.25% | -8.45% | -9.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.51% | 6.87% | -1.25% | -8.45% | -9.12% |
| Cost of Revenue | 12.68% | 3.34% | -16.65% | -1.59% | -13.57% |
| Gross Profit | 12.48% | 7.41% | 1.72% | -9.58% | -8.37% |
| SG&A Expenses | -12.55% | -21.40% | -14.71% | -10.54% | -7.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.84% | -22.41% | -20.31% | -8.20% | -7.71% |
| Operating Income | 49.40% | 69.24% | 54.54% | 7.78% | 5.87% |
| Income Before Tax | 8.11% | 64.82% | 24.33% | 3.35% | 13.15% |
| Income Tax Expenses | -73.17% | -78.95% | -147.59% | 166.67% | 141.18% |
| Earnings from Continuing Operations | 8.29% | 64.87% | 26.18% | 3.15% | 12.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.29% | 64.87% | 26.18% | 3.15% | 12.98% |
| EBIT | 49.40% | 69.24% | 54.54% | 7.78% | 5.87% |
| EBITDA | 49.60% | 69.70% | 54.84% | 7.40% | 5.65% |
| EPS Basic | 12.83% | 66.38% | 29.03% | 6.76% | 16.03% |
| Normalized Basic EPS | 49.01% | 66.35% | 51.96% | 6.94% | 4.66% |
| EPS Diluted | 12.83% | 66.38% | 29.03% | 6.76% | 16.03% |
| Normalized Diluted EPS | 49.01% | 66.35% | 51.96% | 6.94% | 4.66% |
| Average Basic Shares Outstanding | 5.17% | 4.50% | 4.05% | 3.84% | 3.65% |
| Average Diluted Shares Outstanding | 5.17% | 4.50% | 4.05% | 3.84% | 3.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |